Patents by Inventor Adriana Sliwa-Primorac

Adriana Sliwa-Primorac has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cosmetic preparations comprising Daphne extracts
    Patent number: 11896707
    Abstract: The present invention relates to the use of plant extracts from the genus Daphne for the cosmetic treatment of the skin and to cosmetic preparations which comprise extracts of Daphne giraldii and/or Daphne gnidium or other members of the genus Daphne containing daphnetoxin and/or other daphnane diterpenoids for skin treatment. The plant extracts and cosmetic preparations are particularly useful for stimulation of the lymphatic system.
    Type: Grant
    Filed: December 10, 2019
    Date of Patent: February 13, 2024
    Assignees: ETH Zurich, Universität Basel
    Inventors: Michael Detmar, Epameinondas Gousopoulos, Olivier Potterat, Jihye Kim, Adriana Sliwa-Primorac, Antonia Elisabeth Schantl, Maria Teresa Faleschini, Matthias Hamburger
  • PROMOTION OF LYMPHATIC FUNCTION
    Publication number: 20220175696
    Abstract: The present invention refers to lipophilic extracts of members of the Iridaceae family, such as Iris germanica and/or Iris pallida, that have been found to promote lymphatic function. These extracts are suitable for the treatment of skin inflammation, rheumatoid arthritis, impaired wound healing, chronic inflammatory diseases, chronic airway inflammation, inflammatory bowel disease, rosacea, primary and/or secondary lymphedemas. The most active components were found to be the iridals.
    Type: Application
    Filed: February 24, 2022
    Publication date: June 9, 2022
    Inventors: Michael Detmar, Matthias Hamburger, Olivier Potterat, Adriana Sliwa-Primorac
  • PROMOTION OF LYMPHATIC FUNCTION
    Publication number: 20200147004
    Abstract: The present invention refers to lipophilic extracts of members of the Iridaceae family, such as Iris germanica and/or Iris pallida, that have been found to promote lymphatic function. These extracts are suitable for the treatment of skin inflammation, rheumatoid arthritis, impaired wound healing, chronic inflammatory diseases, chronic airway inflammation, inflammatory bowel disease, rosacea, primary and/or secondary lymphedemas. The most active components were found to be the iridals.
    Type: Application
    Filed: January 17, 2020
    Publication date: May 14, 2020
    Applicants: UNIVERSITAET BASEL, ETH ZUERICH
    Inventors: Michael Detmar, Matthias Hamburger, Olivier Potterat, Adriana Sliwa-Primorac
  • PROMOTION OF LYMPHATIC FUNCTION
    Publication number: 20160367499
    Abstract: The present invention refers to lipophilic extracts of members of the Iridaceae family, such as Iris germanica and/or Iris pallida, that have been found to promote lymphatic function. These extracts are suitable for the treatment of skin inflammation, rheumatoid arthritis, impaired wound healing, chronic inflammatory diseases, chronic airway inflammation, inflammatory bowel disease, rosacea, primary and/or secondary lymphedemas. The most active components were found to be the iridals.
    Type: Application
    Filed: November 17, 2015
    Publication date: December 22, 2016
    Applicants: UNIVERSITAET BASEL, ETH ZUERICH
    Inventors: Michael Detmar, Matthias Hamburger, Olivier Potterat, Adriana Sliwa-Primorac